DBORA LEE: Open Payments
NPI 1013506146 · MARGATE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,154 in 202 payments from 18 companies in 2025. Trend: 2023 $2,073 · 2024 $4,585 · 2025 $7,154
Food & beverage: $4,586Consulting: $2,420Education: $148
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $1,754 |
| Incyte Corporation | 15 | $1,707 |
| ABBVIE INC. | 39 | $747 |
| Novartis Pharmaceuticals Corporation | 11 | $528 |
| Janssen Biotech, Inc. | 31 | $508 |
| GENZYME CORPORATION | 10 | $356 |
| Regeneron Healthcare Solutions, Inc. | 14 | $344 |
| Galderma Laboratories, L.P. | 10 | $325 |
| Arcutis Biotherapeutics, Inc. | 19 | $257 |
| Organon LLC | 14 | $159 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, OPZELURA, Zoryve, RINVOQ.
Industry payments across FL — which companies pay providers there.
